about
Bile Acid Metabolism and Signaling in Cholestasis, Inflammation, and CancerBiliary lipid composition in cholesterol microlithiasisEffects of cisapride on gall bladder emptying, intestinal transit, and serum deoxycholate: a prospective, randomised, double blind, placebo controlled trialUrsodeoxycholic acid improves gastrointestinal motility defects in gallstone patients.Review article: epidemiology of gall-bladder disease--role of intestinal transit.Review: pathogenesis of gallstones.Identification and characterization of a bile acid 7alpha-dehydroxylation operon in Clostridium sp. strain TO-931, a highly active 7alpha-dehydroxylating strain isolated from human feces.Biliary physiology and disease: reflections of a physician-scientist.Rapid cholesterol nucleation time and cholesterol gall stone formation after subtotal or total colectomy in humans.Effect of octreotide on fasting gall bladder emptying, antroduodenal motility, and motilin release in acromegaly.Assessment of fecal bacteria with bile acid 7 alpha-dehydroxylating activity for the presence of bai-like genes.Altered migrating myoelectrical complex in an animal model of cholesterol gallstone disease: the effect of erythromycin.Prolonged large bowel transit increases serum deoxycholic acid: a risk factor for octreotide induced gallstones.Gallstones and cholecystectomy in modern BritainOctreotide induced prolongation of colonic transit increases faecal anaerobic bacteria, bile acid metabolising enzymes, and serum deoxycholic acid in patients with acromegaly.Disorders of bile acid metabolism in cholesterol gallstone disease.Bile acids in serum and bile of patients with cholesterol gallstone.Current concepts in cholesterol gallstone pathogenesis.Somatostatin analogs and gallstones: a retrospective survey on a large series of acromegalic patients.Increased Risk of Gallstone Disease Following Colectomy for Ulcerative Colitis.Potential of biofluid components to modify silver nanoparticle toxicity.Recent understanding of cholesterol gallstone pathogenesis: implication to non-surgical therapeutic strategy.A clinical hepatologist's predictions about non-absorbed carbohydrates for the early twenty-first century.Effect of lactulose and fiber-rich diets on bile in relation to gallstone disease: an update.Partial replacement of bile salts causes marked changes of cholesterol crystallization in supersaturated model bile systems.Cisapride improves gallbladder emptying and bile lipid composition in patients with gallstones.Influence of pH on the phase distribution of nascent deoxycholic acid in fresh human cecal aspirates.Phosphatidylcholine-enriched diet prevents gallstone formation in mice susceptible to cholelithiasis.Hepatic overexpression of murine Abcb11 increases hepatobiliary lipid secretion and reduces hepatic steatosis.Deoxycholic acid treatment in patients with cholesterol gallstones: failure to detect a suppression of cholesterol 7alpha-hydroxylase activity.
P2860
Q26800206-7532EFF5-0248-4DBB-9952-5905DF8FE0A1Q28362634-3780EC38-0049-43F4-8494-74D9C9B79E16Q28364173-53EBA9E7-9A60-4B1E-8133-461CE0ADFCCFQ33869392-3941D316-AF47-43F7-835C-0318C7D5E173Q33973591-555BA32A-02D3-4686-94AA-25BEE80039EAQ33973631-AD9735D5-19AD-4009-BE4D-081003F357C0Q33986775-9B1423BF-5AA8-44AA-AE83-CD0F485ECE54Q34108895-A0A7138D-8087-46A8-A978-CD81D685EAFAQ34380637-0C98483A-5AD7-4A20-9942-6CCE5954C3DDQ34408333-DECFB1E9-EA03-442E-9030-C4211A8B888AQ35198976-3183228B-AB60-4870-919C-AEF4CE67E1CFQ35353756-BA6D422C-B1B9-4DAC-9BA8-F09CE0F93E20Q35355172-F7DE6402-87B7-4459-BD8C-5D9A538BB502Q35509985-D1550CB1-551B-4D6D-8CA1-AF77D280717EQ35597307-138CA793-2580-4296-835D-E20C70FCCE24Q35821669-7C4A64B2-6C59-4FA8-A83C-D8B37532AD88Q36620300-1946AA9D-A3E6-49B8-9A30-B9F8776EB623Q36830809-452B44C8-2182-4358-9622-D5899B3E94A8Q37292997-C7BF203C-D22A-4A4F-A598-FD4FA27905F2Q38403163-A0FF161D-8217-49F1-8782-471C3EAB0C34Q38902155-07ADCCCF-1B95-4FB4-B4A2-DFDA2CF0B248Q40041443-FF86A77C-BA51-4740-BE88-DA38A1981FEEQ40913085-0AD80563-1CE8-4336-9254-A676E6E3E44BQ41466129-AE73C20B-3833-47D3-A0AF-57A5A3E5B080Q42158826-19000C48-6E38-4A53-9FA9-2A37535F4FC5Q43669358-44666CDB-4C5A-49F5-B7E8-BA7AEC93473CQ43669411-332D3EAB-8761-4E77-865E-910E74CBD26DQ44499479-1E6B4534-826E-4287-8A3B-3DB31B26D25DQ44626804-DC45D732-3FE8-4D04-AEA9-82C0B80728E2Q50190415-CE920348-B696-4339-A4C4-72462A6D9A75
P2860
description
1988 nî lūn-bûn
@nan
1988 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
1988 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
1988年の論文
@ja
1988年論文
@yue
1988年論文
@zh-hant
1988年論文
@zh-hk
1988年論文
@zh-mo
1988年論文
@zh-tw
1988年论文
@wuu
name
Deoxycholic acid and the pathogenesis of gall stones.
@ast
Deoxycholic acid and the pathogenesis of gall stones.
@en
Deoxycholic acid and the pathogenesis of gall stones.
@nl
type
label
Deoxycholic acid and the pathogenesis of gall stones.
@ast
Deoxycholic acid and the pathogenesis of gall stones.
@en
Deoxycholic acid and the pathogenesis of gall stones.
@nl
prefLabel
Deoxycholic acid and the pathogenesis of gall stones.
@ast
Deoxycholic acid and the pathogenesis of gall stones.
@en
Deoxycholic acid and the pathogenesis of gall stones.
@nl
P2860
P356
P1433
P1476
Deoxycholic acid and the pathogenesis of gall stones.
@en
P2093
P2860
P304
P356
10.1136/GUT.29.4.522
P407
P577
1988-04-01T00:00:00Z